Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD — Stella

Home/Generalized Anxiety Disorder/Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD

View on ClinicalTrials.gov

Recruiting

Back to Generalized Anxiety Disorder trials

Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Beijing Union Pharmaceutical Factory Ltd, Beijing, Beijing Municipality

Key details

Phase

Large-scale testing

Sponsor

Beijing Union Pharmaceutical Factory Ltd

Collaborators

R&G Pharma Studies Co.,Ltd.

Enrollment target

~410 participants

Started

July 2023

Primary completion

June 2026

Age range

18 Years – 65 Years

Last updated February 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.